2026년 9월 3일•1분 읽기
Temporary Reimbursement Granted for Pediatric Smectite After Indication Removal
Korean Pharmaceutical Association secured a three‑day temporary reimbursement for di‑octahedral smectite dispensed to patients under 19, easing pharmacy billing concerns after pediatric indication was withdrawn.